Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $337.89 | $19.27 | 1,653.23% | 6,757.80x | 101.28x | 7.49x | 9.06x | 6.53x | $529.27M | 1.42% | $4.13B | 37.48 | $35.30B | 110.98 | ||
| NVO | NOVO NORDISK A S | $58.81 | $148.91 | -60.51% | 16.35x | 2.55x | 5.37x | 9.98x | 0.17x | $9.34B | 3.57% | $26.18B | 5.89 | $271.97B | 10.96 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $398.29 | $36.78 | 983.04% | 1,284.81x | 57.23x | 16.31x | 224.97x | 4.17x | $221.36M | 0.42% | $233.89M | 1.78 | $54.34B | 357.69 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.67 | $17.35 | 145.95% | 87.08x | 24.80x | 5.33x | 6.04x | 1.08x | $101.73M | 3.19% | $535.38M | 7.17 | $3.07B | 57.28 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.49 | $16.44 | -48.35% | 17.69x | 14.93x | 5.63x | 3.59x | 0.23x | -$23.64M | -4.98% | $133.17M | 2.38 | $486.24M | 7.24 | ||
| CORT | CORCEPT THERAPEUTICS INC | $37.50 | $43.13 | -13.06% | 37.50x | 34.12x | 5.24x | 6.24x | 0.37x | $162.57M | 4.19% | $631.90M | 6.10 | $3.83B | 57.99 | ||
| ARGX | ARGENX SE | $788.49 | $362.35 | 117.61% | 31.51x | 26.71x | 25,435.16x | 6.71x | 1.32x | $467.72M | 0.97% | $7.17B | 117.50 | $45.72B | 56.36 | ||
| VCEL | VERICEL CORP | $38.56 | $9.55 | 303.87% | 148.31x | 66.32x | 7.53x | 6.06x | 1.76x | $20.38M | 1.05% | $321.86M | 6.38 | $1.95B | 66.45 | ||
| KRYS | KRYSTAL BIOTECH INC | $261.41 | $115.85 | 125.64% | 37.89x | 32.58x | 20.28x | 6.66x | 1.26x | $166.02M | 2.19% | $1.14B | 39.30 | $7.20B | 37.23 | ||
| ADMA | ADMA BIOLOGICS INC | $17.95 | $12.74 | 40.94% | 20.40x | 20.00x | 8.76x | 9.91x | 0.86x | $40.73M | 0.95% | $431.19M | 1.81 | $4.28B | 24.89 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.19 | $19.12 | -72.86% | 3.26x | -96.29x | 741.43x | 1.64x | 0.19x | -$82.36M | -29.25% | $171.23M | 3.16 | $222.14M | 2.47 | ||
| TECH | BIO-TECHNE CORP | $65.70 | $16.30 | 303.11% | 131.40x | 32.49x | 8.40x | 5.21x | 1.80x | $224.06M | 2.19% | $1.97B | 12.65 | $10.49B | 47.47 | ||
| GMAB | GENMAB A | $34.26 | $128.15 | -73.27% | 14.62x | 1.96x | 6.17x | 3.82x | 0.11x | $1.19B | 5.43% | $5.75B | 8.96 | $20.38B | 10.18 | ||
| RPRX | ROYALTY PHARMA PLC | $40.18 | $47.26 | -14.99% | 22.83x | 7.76x | 7.38x | 2.41x | 0.40x | $2.11B | 12.17% | $9.62B | 22.28 | $31.20B | 29.88 | ||
| XOMA | XOMA ROYALTY CORP | $29.85 | $15.86 | 88.26% | 36.85x | 94.94x | 7.69x | 4.20x | 0.98x | -$12.41M | -3.42% | $87.94M | 7.25 | $411.07M | 15.37 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $206.65 | $72.39 | 185.49% | 89.46x | 24.56x | 16.10x | 4.28x | 1.28x | $30.76M | 0.76% | $950.17M | 48.53 | $4.38B | 42.51 | ||
| CRMD | CORMEDIX INC | $7.63 | $17.84 | -57.23% | 3.36x | 3.03x | 2.70x | 1.61x | 0.58x | $74.42M | 12.84% | $374.13M | 4.93 | $701.59M | 6.25 | ||
| MNKD | MANNKIND CORP | $5.85 | $2.78 | 110.23% | 58.50x | 53.33x | 5.72x | -40.32x | 0.97x | $43.39M | 2.41% | -$44.55M | -0.15 | $2.03B | 27.72 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.52 | $4.33 | 50.73% | 24.15x | 21.67x | 4.17x | 7.36x | 0.86x | $21.15M | 4.06% | $70.68M | 0.89 | $459.10M | 20.23 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.15 | $9.85 | 53.77% | 26.12x | 15.89x | 7.51x | 5.46x | 0.85x | $119.87M | 6.00% | $365.77M | 2.78 | $2.00B | 19.34 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.55 | $61.29 | -37.10% | 11.93x | 9.12x | 2.69x | 2.66x | 0.33x | $296.89M | 13.38% | $835.12M | 14.51 | $1.74B | 6.46 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $463.86 | $190.61 | 143.36% | 32.42x | 22.68x | 10.11x | 6.80x | 1.57x | $3.34B | 2.81% | $17.32B | 67.76 | $114.59B | 24.58 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.07 | $3.58 | -42.11% | 29.57x | 11.71x | 2.65x | 3.15x | 0.24x | -$11.69M | -7.10% | $52.91M | 0.67 | $161.00M | 18.15 | ||
| VCYT | VERACYTE INC | $42.04 | $12.34 | 240.73% | 107.79x | 39.96x | 6.68x | 2.64x | 1.53x | $98.21M | 2.97% | $1.26B | 15.98 | $3.05B | 53.45 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.95 | $51.46 | 14.56% | 21.67x | 13.08x | 3.66x | 1.87x | 0.60x | $832.13M | 7.35% | $6.06B | 31.54 | $10.67B | 13.81 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $27.30 | $6.68 | 308.46% | 78.00x | -24.58x | 3.40x | 8.61x | 2.14x | $78.64M | 2.28% | $401.17M | 3.17 | $3.45B | 36.94 | ||
| EXEL | EXELIXIS INC | $44.04 | $36.60 | 20.32% | 17.90x | 13.94x | 5.17x | 5.46x | 0.72x | $779.77M | 6.60% | $2.16B | 8.05 | $11.61B | 12.51 | ||
| HALO | HALOZYME THERAPEUTICS INC | $72.47 | $80.86 | -10.37% | 14.82x | 8.74x | 6.83x | 16.91x | 0.50x | $602.40M | 7.09% | $503.92M | 4.30 | $9.61B | 11.37 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.72 | $22.66 | 0.26% | 12.69x | 11.65x | 4.82x | 3.03x | 0.67x | $234.54M | 8.42% | $920.25M | 7.51 | $2.11B | 6.50 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $796.55 | $413.02 | 92.86% | 18.33x | 17.29x | 5.79x | 2.70x | 1.79x | $4.22B | 5.12% | $30.96B | 298.82 | $83.92B | 14.69 | ||
| MDXG | MIMEDX GROUP INC | $6.10 | $5.06 | 20.46% | 21.79x | 24.41x | 2.29x | 3.78x | 0.65x | $66.82M | 7.39% | $238.95M | 1.61 | $779.55M | 11.26 | ||
| INVA | INNOVIVA INC | $19.58 | $19.41 | 0.88% | 10.36x | 8.96x | 3.48x | 1.45x | 0.84x | $196.54M | 14.54% | $1.01B | 14.63 | $1.24B | 5.80 | ||
| UTHR | UNITED THERAPEUTICS CORP | $483.23 | $251.65 | 92.03% | 16.97x | 16.24x | 6.77x | 3.16x | 2.02x | $1.12B | 5.30% | $6.59B | 150.46 | $19.47B | 10.98 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.78 | $12.37 | 116.50% | 17.06x | 33.26x | 4.32x | 4.94x | 2.94x | $197.81M | 4.38% | $917.27M | 5.43 | $4.31B | 14.97 | ||
| INCY | INCYTE CORP | $106.87 | $77.44 | 38.01% | 17.69x | 13.28x | 4.34x | 4.51x | 0.92x | $1.20B | 5.72% | $4.65B | 23.77 | $18.56B | 11.03 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.